State Ledger
Company profile

Beta Bionics, Inc. CIK 1674632

Ticker
BBNX (Nasdaq)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Irvine, CA 92618
Fiscal year end
2025 (FY)
Market Data
Close
$17.64
Change
+$0.20
Change %
1.15%
Volume
67,133

BBNX · trading date Oct 9, 2026 · previous close $17.44 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$100.25M
Net income
-$73.20M
Total assets
$328.74M
Total liabilities
$41.13M
Stockholders' equity
$287.61M
Cash & equivalents
$31.58M
Operating income
-$71.68M
Operating cash flow
-$50.93M
Capital expenditures
$5.30M

Fiscal year 2025, via 10-K filed 2026-02-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-71.5%
Net margin
-73.0%
Free cash flow
-$56.22M
Free cash flow margin
-56.1%
Liabilities / assets
12.5%
Equity / assets
87.5%
CapEx / revenue
5.3%
Operating cash flow / net income
0.70×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $100.25M -$73.20M $328.74M $41.13M $287.61M
2024 $65.12M -$54.76M $149.65M $73.63M -$245.36M
2023 $12.00M -$44.10M $110.04M $51.43M -$203.11M
Company Details
SIC code
3841
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4/A
2026-09-18
Financials filed via
Form 10-K
filed 2026-02-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Irvine, CA 92618
11 HUGHES
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies